Clinical trials in psychiatry: should protocol deviation censor patient data?
about
Serenoa repens for benign prostatic hyperplasiaA double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD)The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trialsToward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.Intention-to-treat meets missing data: implications of alternate strategies for analyzing clinical trials dataThe association of dropout and outcome in trials of antipsychotic medication and its implications for dealing with missing data.Missing Data in Longitudinal Trials - Part B, Analytic Issues.Missing Data in Longitudinal Clinical Trials Part A: Design and Conceptual Issues.Enhancing clinical trial design of interventions for posttraumatic stress disorderAddressing missing data in clinical trialsSustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.Working Inside for Smoking Elimination (Project W.I.S.E.) study design and rationale to prevent return to smoking after release from a smoke free prison.Intent-to-Treat vs. Non-Intent-to-Treat Analyses under Treatment Non-Adherence in Mental Health Randomized Trials.Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BDMethodological issues in current antipsychotic drug trials.Community vs. clinic-based modular treatment of children with early-onset ODD or CD: a clinical trial with 3-year follow-up.Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: randomised controlled non-inferiority trial.Choosing a behavioral therapy platform for pharmacotherapy of substance users.Including all individuals is not enough: lessons for intention-to-treat analysis.A methodological analysis of randomized clinical trials of computer-assisted therapies for psychiatric disorders: toward improved standards for an emerging field.Methods for testing theory and evaluating impact in randomized field trials: intent-to-treat analyses for integrating the perspectives of person, place, and time.The impact of analytic method on interpretation of outcomes in longitudinal clinical trialsComparison of behavioral treatment conditions in buprenorphine maintenance.The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials.Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research.
P2860
Q24241144-91EE46E5-E4AB-4168-8850-5CA5C7865106Q24624661-0C271686-C908-49FB-8B22-4BBF5511D1A7Q24795674-D5F07334-F998-43C7-93ED-C1BE232E1A94Q30579736-3C52507E-04F9-49A3-ACF5-2D7CB88BBFF3Q30724117-D8A84E46-F764-4111-BCB6-3BE6BB2E1712Q31143463-1A69B8A5-CC54-4EFA-AD38-D0FEE3831F77Q33492294-60A4C8EB-5C8D-4808-99B2-A77453D29021Q33503655-CA3042AB-B408-4D1B-978B-6F5376A9EB99Q33560607-96F5B81E-4132-4F7A-8E5E-F648EECC2224Q33795600-C8AC625F-0727-498C-8B4F-7BD78D0AAE7CQ34021980-251159DE-893F-4F4A-9FC5-4CBAF41292ADQ34040800-E065446C-5AF8-40D7-844D-8EC2314842C3Q34066072-7F492052-EBE8-4B5B-8376-26F4A66A2E60Q34575982-9EE36AF0-F5DA-4A2F-8515-FE4EF7EC7BB9Q34587745-C4805624-5EFB-4A68-BCD3-8A49CC2A7AD7Q34946610-9B20FBEB-4F75-4B84-B950-81036C99AA9FQ35112890-472A950F-6EED-4099-8818-DCF28E08FF16Q35846758-64F9820A-2E9A-406C-9DD3-2D7BCD643C88Q36191875-1346D219-18B7-4284-AD8A-4A1C8147A7BAQ36713308-C882833B-2DDA-4696-9F37-21FC451B7B2CQ36920488-96E548A0-E431-4D0B-85AF-134318A6E0BEQ37134325-382E2C18-F68B-43BB-8240-FAC9F5F27A4AQ37400852-C0CAE0C5-20FF-44A0-B35C-7E939E0EC327Q39039330-61C8386F-3A10-4F7B-8B0C-36FCE44AB3EEQ41815876-9AAB0A07-1167-45A1-96DC-2F8D8486349CQ41898574-043252DE-84A2-45C8-978F-444FA63D796F
P2860
Clinical trials in psychiatry: should protocol deviation censor patient data?
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Clinical trials in psychiatry: should protocol deviation censor patient data?
@ast
Clinical trials in psychiatry: should protocol deviation censor patient data?
@en
type
label
Clinical trials in psychiatry: should protocol deviation censor patient data?
@ast
Clinical trials in psychiatry: should protocol deviation censor patient data?
@en
prefLabel
Clinical trials in psychiatry: should protocol deviation censor patient data?
@ast
Clinical trials in psychiatry: should protocol deviation censor patient data?
@en
P1476
Clinical trials in psychiatry: should protocol deviation censor patient data?
@en
P2093
P W Lavori
P304
39-48; discussion 49-63
P407
P577
1992-01-01T00:00:00Z